Mark A. Lovell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark A. Lovell has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Chengsong Xie
Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA
7 shared publicationsWilliam R. Markesbery
Departments of Neurology and Pathology, University of Kentucky, Lexington, KY 40536-0230, USA
5 shared publicationsWilliam R Markesbery
4 shared publicationsShuling Xiong
Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA
2 shared publicationsAdam M. Weidner
Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America
1 shared publicationAmy L. S. Dowling
Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America
1 shared publication
Latest Publications
- Open Access
- 20 September 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e24930
RNA Oxidation Adducts 8-OHG and 8-OHA Change with Aβ42 Levels in Late-Stage Alzheimer's Disease
While research supports amyloid-β (Aβ) as the etiologic agent of Alzheimer's disease (AD), the mechanism of action remains unclear. Evidence indicates that adducts of RNA caused by oxidation also represent an early phenomenon in AD. It is currently unknown what type of influence these two observations have on each other, if any. We quantified five RNA adducts by gas chromatography/mass spectroscopy across five brain regions from AD cases and age-matched controls. We then used a reductive directed analysis to compare the RNA adducts to common indices of AD neuropathology and various pools of Aβ. Using data from four disease-affected brain regions (Brodmann's Area 9, hippocampus, inferior parietal lobule, and the superior and middle temporal gyri), we found that the RNA adduct 8-hydroxyguanine (8-OHG) decreased, while 8-hydroxyadenine (8-OHA) increased in AD. The cerebellum, which is generally spared in AD, did not show disease related changes, and no RNA adducts correlated with the number of plaques or tangles. Multiple regression analysis revealed that SDS-soluble Aβ42 was the best predictor of changes in 8-OHG, while formic acid-soluble Aβ42 was the best predictor of changes in 8-OHA. This study indicates that although there is a connection between AD related neuropathology and RNA oxidation, this relationship is not straightforward.
- 20 September 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9) , e24930
Open AccessRNA Oxidation Adducts 8-OHG and 8-OHA Change with Aβ42 Levels in Late-Stage Alzheimer's Disease
While research supports amyloid-β (Aβ) as the etiologic agent of Alzheimer's disease (AD), the mechanism of action remains unclear. Evidence indicates that adducts of RNA caused by oxidation also represent an early phenomenon in AD. It is currently unknown what type of influence these two observations have on each other, if any. We quantified five RNA adducts by gas chromatography/mass spectroscopy across five brain regions from AD cases and age-matched controls. We then used a reductive directed analysis to compare the RNA adducts to common indices of AD neuropathology and various pools of Aβ. Using data from four disease-affected brain regions (Brodmann's Area 9, hippocampus, inferior parietal lobule, and the superior and middle temporal gyri), we found that the RNA adduct 8-hydroxyguanine (8-OHG) decreased, while 8-hydroxyadenine (8-OHA) increased in AD. The cerebellum, which is generally spared in AD, did not show disease related changes, and no RNA adducts correlated with the number of plaques or tangles. Multiple regression analysis revealed that SDS-soluble Aβ42 was the best predictor of changes in 8-OHG, while formic acid-soluble Aβ42 was the best predictor of changes in 8-OHA. This study indicates that although there is a connection between AD related neuropathology and RNA oxidation, this relationship is not straightforward.
- 1 July 2006
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (7) , 909-917
Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain
- 1 July 2006
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (7) , 909-917
Isolation of neural precursor cells from Alzheimer's disease and aged control postmortem brain
- 1 September 2003
- Published by Elsevier in Brain Research
- Vol. 983 (1-2) , 84-96
Wilms’ tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer’s disease
- 1 September 2003
- Published by Elsevier in Brain Research
- Vol. 983 (1-2) , 84-96
Wilms’ tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer’s disease
- 24 July 2003
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 5 (3) , 229-239
Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid
Current evidence supports the role of oxidative stress in the pathogenesis of neuron degeneration in Alzheimer's disease (AD). α-Lipoic acid (LA), an essential cofactor in mitochondrial dehydrogenase reactions, functions as an antioxidant and reduces
- 24 July 2003
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 5 (3) , 229-239
Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid
Current evidence supports the role of oxidative stress in the pathogenesis of neuron degeneration in Alzheimer's disease (AD). α-Lipoic acid (LA), an essential cofactor in mitochondrial dehydrogenase reactions, functions as an antioxidant and reduces
- 1 March 2002
- Published by Elsevier in Neurobiology of Aging
- Vol. 23 (2) , 179-186
Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease
- 1 March 2002
- Published by Elsevier in Neurobiology of Aging
- Vol. 23 (2) , 179-186
Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease
- Open Access
- 1 March 2001
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (3) , 392-396
Ratio of 8-Hydroxyguanine in Intact DNA to Free 8-Hydroxyguanine Is Increased in Alzheimer Disease Ventricular Cerebrospinal Fluid
INCREASING evidence supports the role of oxidative stress in the pathogenesis of neuronal degeneration in several neurological disorders, including stroke, amyotrophic lateral sclerosis, Parkinson disease, head trauma, and Alzheimer disease (AD). Several studies show that the AD brain has the potential for increased oxidative stress due to elevations of brain iron levels, particularly redox active iron.1,2 Studies of oxidative damage show increased levels of protein oxidation, lipid peroxidation, and markers of lipid peroxidation, including 4-hydroxynonenal2 and acrolein,3,4 F2-isoprostanes,5 and F4-neuroprotanes6 in AD. Increased levels of 4-hydroxynonenal, F2-isoprostanes, and F4-neuroprostanes are present in ventricular cerebrospinal fluid (CSF) in AD. Markers of oxidative stress are present in neurofibrillary tangles and senile plaques in the brain in AD. Two markers of oxidative stress in nuclear and mitochondrial DNA are increased in normal aging7 and in AD.8-10 Attack of DNA by reactive oxygen species, specifically the hydroxyl radical, leads to the hydroxylation of DNA bases,11 the most prominent of which is 8-hydrodeoxyguanine (8-OHdG). Levels of 8-OHdG are elevated in mitochondrial DNA in the cerebral cortex of patients with AD compared with controls.10 Our laboratory demonstrated statistically significant (P8 Of the 6 oxidatively modified base adducts analyzed, 8-OHG demonstrated the highest absolute levels, indicating its prominence as a marker of oxidative stress in AD. Consistent with observations of elevated 8-OHG in the AD brain, we recently demonstrated a statistically significant (P12 In another study, we showed statistically significant (P13 Analysis of levels of free 8-OHG, resulting from excision from damaged DNA by base-specific glycosylases, demonstrated a statistically significant depletion of the free repair product in AD CSF. Although mean levels of free and intact 8-OHG were significantly (P<0.5) different in 8-OHG AD subjects compared with control subjects, overlap of the data showed that the individual measures alone were not appropriate as diagnostic markers of AD.
- 1 March 2001
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (3) , 392-396
Open AccessRatio of 8-Hydroxyguanine in Intact DNA to Free 8-Hydroxyguanine Is Increased in Alzheimer Disease Ventricular Cerebrospinal Fluid
INCREASING evidence supports the role of oxidative stress in the pathogenesis of neuronal degeneration in several neurological disorders, including stroke, amyotrophic lateral sclerosis, Parkinson disease, head trauma, and Alzheimer disease (AD). Several studies show that the AD brain has the potential for increased oxidative stress due to elevations of brain iron levels, particularly redox active iron.1,2 Studies of oxidative damage show increased levels of protein oxidation, lipid peroxidation, and markers of lipid peroxidation, including 4-hydroxynonenal2 and acrolein,3,4 F2-isoprostanes,5 and F4-neuroprotanes6 in AD. Increased levels of 4-hydroxynonenal, F2-isoprostanes, and F4-neuroprostanes are present in ventricular cerebrospinal fluid (CSF) in AD. Markers of oxidative stress are present in neurofibrillary tangles and senile plaques in the brain in AD. Two markers of oxidative stress in nuclear and mitochondrial DNA are increased in normal aging7 and in AD.8-10 Attack of DNA by reactive oxygen species, specifically the hydroxyl radical, leads to the hydroxylation of DNA bases,11 the most prominent of which is 8-hydrodeoxyguanine (8-OHdG). Levels of 8-OHdG are elevated in mitochondrial DNA in the cerebral cortex of patients with AD compared with controls.10 Our laboratory demonstrated statistically significant (P8 Of the 6 oxidatively modified base adducts analyzed, 8-OHG demonstrated the highest absolute levels, indicating its prominence as a marker of oxidative stress in AD. Consistent with observations of elevated 8-OHG in the AD brain, we recently demonstrated a statistically significant (P12 In another study, we showed statistically significant (P13 Analysis of levels of free 8-OHG, resulting from excision from damaged DNA by base-specific glycosylases, demonstrated a statistically significant depletion of the free repair product in AD CSF. Although mean levels of free and intact 8-OHG were significantly (P<0.5) different in 8-OHG AD subjects compared with control subjects, overlap of the data showed that the individual measures alone were not appropriate as diagnostic markers of AD.
- 1 March 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (5) , 665-672
Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium
- 1 March 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (5) , 665-672
Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium
- 28 February 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (3) , 418-427
Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain
- 28 February 2000
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 28 (3) , 418-427
Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain
- 1 February 2000
- Published by Elsevier in Brain Research
- Vol. 855 (1) , 116-123
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain
- 1 February 2000
- Published by Elsevier in Brain Research
- Vol. 855 (1) , 116-123
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain
- 1 March 1999
- Published by Elsevier in Brain Research
- Vol. 823 (1-2) , 88-95
Protection against amyloid beta peptide toxicity by zinc
- 1 March 1999
- Published by Elsevier in Brain Research
- Vol. 823 (1-2) , 88-95
Protection against amyloid beta peptide toxicity by zinc